ITGB2 can significantly predict OS in all grades of gliomas(Since Rembrant’s Microarray dataset does not have IDH mutation status information, we cannot verify it in Rembrant’s Microarray dataset). This evidence concerns the gene ITGB2 and central nervous system cancer.